{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:27:56Z","timestamp":1791660476834,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Alexion Pharma France SAS"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.atherosclerosis.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T23:15:19Z","timestamp":1534547719000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6000-5028","authenticated-orcid":false,"given":"Sophie","family":"Beliard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8887-994X","authenticated-orcid":false,"given":"Antonio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Duch\u00eane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Carri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-5184","authenticated-orcid":false,"given":"M. John","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bruckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Saheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4145","key":"10.1016\/j.atherosclerosis.2018.08.007_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.185.4145.61","article-title":"Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man","volume":"185","author":"Brown","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib2","series-title":"The Metabolic Basis of Inherited Disease","first-page":"1981","article-title":"Familial Hypercholesterolemia","author":"Goldstein","year":"1995"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2018.08.007_bib3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur. Heart J."},{"issue":"7537","key":"10.1016\/j.atherosclerosis.2018.08.007_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.007_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001236","article-title":"Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010","volume":"3","author":"Mundal","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.08.007_bib6","first-page":"49","article-title":"Familial hypercholesterolaemia","volume":"25","author":"Marais","year":"2004","journal-title":"Clin. Biochem. Rev."},{"issue":"32","key":"10.1016\/j.atherosclerosis.2018.08.007_bib7","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2017.01.015","article-title":"Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France","volume":"257","author":"Bruckert","year":"2017","journal-title":"Atherosclerosis"},{"issue":"7918","key":"10.1016\/j.atherosclerosis.2018.08.007_bib9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(75)92193-5","article-title":"Plasma exchange in the management of homozygous familial hypercholesterolaemia","volume":"1","author":"Thompson","year":"1975","journal-title":"Lancet"},{"issue":"8254","key":"10.1016\/j.atherosclerosis.2018.08.007_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91213-7","article-title":"Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia","volume":"2","author":"Stoffel","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2008.02.009","article-title":"Recommendations for the use of LDL apheresis","volume":"98","author":"Thompson","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5551\/jat.14621","article-title":"Guidelines for the management of familial hypercholesterolemia","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J. Atherosclerosis Thromb."},{"issue":"3 Suppl","key":"10.1016\/j.atherosclerosis.2018.08.007_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J. Clin. Lipidol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.08.007_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0b013e3283402f53","article-title":"Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe","volume":"21","author":"Thompson","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.08.007_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0021-9150(00)00371-3","article-title":"The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels","volume":"152","author":"Kroon","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9149(97)00947-8","article-title":"Long-term effects of low-density lipoprotein apheresis using an automated dextran sulphate cellulose adsorption system","volume":"81","author":"Gordon","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/039139880402700209","article-title":"Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001","volume":"27","author":"Krebs","year":"2004","journal-title":"Int. J. Artif. Organs"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.08.007_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1526-0968.2000.00180.x","article-title":"Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies","volume":"4","author":"Bambauer","year":"2000","journal-title":"Ther. Apher."},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0140-6736(93)92542-2","article-title":"LDL-apheresis with dextran sulphate and anaphylactoid reaction to ACE inhibitors [letter]","volume":"341","author":"Keller","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCULATIONAHA.117.029435","article-title":"The low-density lipoprotein receptor genotype is a significant determinant of the rebound in low-density lipoprotein cholesterol concentration after lipoprotein apheresis among patients with homozygous familial hypercholesterolemia","volume":"136","author":"Drouin-Chartier","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.08.007_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jca.20036","article-title":"Long-term effects of LDL apheresis in patients with severe hypercholesterolemia","volume":"20","author":"Sachais","year":"2005","journal-title":"Clin. Apher."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.08.007_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.acvd.2012.05.011","article-title":"Severe familial hypercholesterolaemia: current and future management","volume":"105","author":"Farnier","year":"2012","journal-title":"Arch. Cardiovasc Dis."},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib26","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.08.007_bib27","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/eurheartj\/ehw388","article-title":"Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial","volume":"37","author":"Moriarty","year":"2016","journal-title":"Eur. Heart J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:51:11Z","timestamp":1558630271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018312541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":27,"alternative-id":["S0021915018312541"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}